Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

DAVITA INC. Director's Dealing 2014

Mar 7, 2014

30643_dirs_2014-03-07_ebf9c203-0649-4f32-a77b-9dd2da270d74.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DAVITA HEALTHCARE PARTNERS INC. (DVA)
CIK: 0000927066
Period of Report: 2014-03-05

Reporting Person: Rodriguez Javier (President of DaVita)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2014-03-05 Common Stock M 51333 $31.70 Acquired 122597 Direct
2014-03-05 Common Stock F 23670 $68.75 Disposed 98927 Direct
2014-03-05 Common Stock S 27663 $68.3954 Disposed 71264 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2014-03-05 Stock Appreciation Right $31.70 M 51333 Disposed 2015-03-31 Common Stock (51333) Direct

Footnotes

F1: Represents the weighted average sale price of $68.3954. The range of prices for the sale of these shares was $68.3407 - $68.83, rounded to the nearest hundreths. The reporting person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares purchased or sold at each separate price.

F2: Stock Appreciation Rights, granted on 3/31/10, pursuant to the DaVita Inc. 2002 Equity Compensation Plan, (as amended and restated, the "DaVita HealthCare Partners Inc. 2011 Incentive Award Plan," effective June 6, 2011), which vested 33.3% on the second anniversary of the grant date, and 8.33% every 3 months thereafter.